Cullinan Therapeutics, Inc. CGEM Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s non-controlling interests?
- Cullinan Therapeutics, Inc. (CGEM) reported non-controlling interests of $0 in Q4 2025.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s non-controlling interests?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s non-controlling interests has grown at a -100.0% compound annual growth rate (CAGR), from $1.3M to $0.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.